OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Share Price

Certificat

DE000GQ25FA4

Real-time BOERSE MUENCHEN 11:26:55 05/06/2024 BST
7.34 EUR +0.14% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month+4.27%
1 month+16.16%
Date Price Change
05/06/24 7.34 +0.14%
04/06/24 7.33 +4.12%
03/06/24 7.04 +0.14%
31/05/24 7.03 -1.95%
30/05/24 7.17 -2.18%

Real-time BOERSE MUENCHEN

Last update June 05, 2024 at 11:26 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ25FA
ISINDE000GQ25FA4
Date issued 15/08/2023
Strike 263.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.39
Lowest since issue 0.77
Spread 0.07
Spread %0.94%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
342 USD
Average target price
373.1 USD
Spread / Average Target
+9.08%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW